Stockreport

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry...

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Executed Non-Binding Term Sheet with initial clinic partners generating annual revenue of over $10 million , with additional partners to be selected under this initial [Read more]